{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:50:20Z","timestamp":1787590220530,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T00:00:00Z","timestamp":1066953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T00:00:00Z","timestamp":1066953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,11,1]]},"DOI":"10.1038\/sj.leu.2403081","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T08:12:43Z","timestamp":1066983163000},"page":"2149-2156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL"],"prefix":"10.1038","volume":"17","author":[{"given":"T","family":"Szczepa\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V H J van der","family":"Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Raff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C H","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R van","family":"Wering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kneba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J M van","family":"Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,24]]},"reference":[{"key":"BF2403081_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","volume":"2","author":"T Szczepa\u0144ski","year":"2001","unstructured":"Szczepa\u0144ski T, Orfao A, van der Velden VHJ, San Miguel JF, van Dongen JJM . Minimal residual disease in leukaemia patients. Lancet Oncol 2001; 2: 409\u2013417.","journal-title":"Lancet Oncol"},{"key":"BF2403081_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. N Engl J Med 1998; 339: 591\u2013598.","journal-title":"N Engl J Med"},{"key":"BF2403081_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM Van Dongen","year":"1998","unstructured":"Van Dongen JJM, Seriu T, Panzer-Gr\u00fcmayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731\u20131738.","journal-title":"Lancet"},{"key":"BF2403081_CR4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","volume":"96","author":"E Coustan-Smith","year":"2000","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000; 96: 2691\u20132696.","journal-title":"Blood"},{"key":"BF2403081_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","volume":"99","author":"C Nyvold","year":"2002","unstructured":"Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002; 99: 1253\u20131258.","journal-title":"Blood"},{"key":"BF2403081_CR6","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","volume":"99","author":"MJ Willemse","year":"2002","unstructured":"Willemse MJ, Seriu T, Hettinger K, d\u2019Aniello E, Hop WCJ, Panzer-Gr\u00fcmayer ER et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor-B-ALL. Blood 2002; 99: 4386\u20134393.","journal-title":"Blood"},{"key":"BF2403081_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.leu.2401780","volume":"14","author":"CH Pui","year":"2000","unstructured":"Pui CH, Campana D . New definition of remission in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 783\u2013785.","journal-title":"Leukemia"},{"key":"BF2403081_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/beha.2002.0184","volume":"15","author":"T Szczepa\u0144ski","year":"2002","unstructured":"Szczepa\u0144ski T, Flohr T, van der Velden VHJ, Bartram CR, van Dongen JJM . Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002; 15: 37\u201357.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BF2403081_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2401245","volume":"13","author":"MJ Pongers-Willemse","year":"1999","unstructured":"Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P et al. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110\u2013118.","journal-title":"Leukemia"},{"key":"BF2403081_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","volume":"14","author":"OJHM Verhagen","year":"2000","unstructured":"Verhagen OJHM, Willemse MJ, Breunis WB, Wijkhuijs AJM, Jacobs DCH, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426\u20131435.","journal-title":"Leukemia"},{"key":"BF2403081_CR11","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","volume":"14","author":"M Br\u00fcggemann","year":"2000","unstructured":"Br\u00fcggemann M, Droese J, Bolz I, Luth P, Pott C, von Neuhoff N et al. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 2000; 14: 1419\u20131425.","journal-title":"Leukemia"},{"key":"BF2403081_CR12","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","volume":"95","author":"JW Donovan","year":"2000","unstructured":"Donovan JW, Ladetto M, Zou G, Neuberg D, Poor C, Bowers D et al. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 2000; 95: 2651\u20132658.","journal-title":"Blood"},{"key":"BF2403081_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/sj.leu.2402475","volume":"16","author":"VHJ Van der Velden","year":"2002","unstructured":"Van der Velden VHJ, Willemse MJ, van der Schoot CE, van Wering ER, van Dongen JJM . Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: 928\u2013936.","journal-title":"Leukemia"},{"key":"BF2403081_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/sj.leu.2402515","volume":"16","author":"VHJ Van der Velden","year":"2002","unstructured":"Van der Velden VHJ, Wijkhuijs JM, Jacobs DCH, van Wering ER, van Dongen JJM . T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16: 1372\u20131380.","journal-title":"Leukemia"},{"key":"BF2403081_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/sj.leu.2402636","volume":"16","author":"VHJ Van der Velden","year":"2002","unstructured":"Van der Velden VHJ, Jacobs DCH, Wijkhuijs AJM, Comans-Bitter WM, Willemse MJ, H\u00e4hlen K et al. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia 2002; 16: 1432\u20131436.","journal-title":"Leukemia"},{"key":"BF2403081_CR16","first-page":"205","volume":"246","author":"T Szczepa\u0144ski","year":"1999","unstructured":"Szczepa\u0144ski T, Pongers-Willemse MJ, Langerak AW, van Dongen JJM . Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias. Curr Top Microbiol Immunol 1999; 246: 205\u2013215.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BF2403081_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/sj.leu.2401970","volume":"15","author":"V De Haas","year":"2001","unstructured":"De Haas V, Verhagen OJ, von dem Borne AE, Kroes W, van den Berg H, van der Schoot CE . Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia 2001; 15: 134\u2013140.","journal-title":"Leukemia"},{"key":"BF2403081_CR18","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1182\/blood.V99.7.2315","volume":"99","author":"T Szczepa\u0144ski","year":"2002","unstructured":"Szczepa\u0144ski T, Willemse MJ, Brinkhof B, van Wering ER, van der Burg M, van Dongen JJM . Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood 2002; 99: 2315\u20132323.","journal-title":"Blood"},{"key":"BF2403081_CR19","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V83.8.2238.2238","volume":"83","author":"A Beishuizen","year":"1994","unstructured":"Beishuizen A, Verhoeven MA, van Wering ER, H\u00e4hlen K, Hooijkaas H, van Dongen JJM . Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994; 83: 2238\u20132247.","journal-title":"Blood"},{"key":"BF2403081_CR20","first-page":"60","volume":"8","author":"JJ Taylor","year":"1994","unstructured":"Taylor JJ, Rowe D, Kylefjord H, Chessells J, Katz F, Proctor SJ et al. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia. Leukemia 1994; 8: 60\u201366.","journal-title":"Leukemia"},{"key":"BF2403081_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2141.1995.tb03384.x","volume":"90","author":"A Baruchel","year":"1995","unstructured":"Baruchel A, Cayuela JM, MacIntyre E, Berger R, Sigaux F . Assessment of clonal evolution at Ig\/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection. Br J Haematol 1995; 90: 85\u201393.","journal-title":"Br J Haematol"},{"key":"BF2403081_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/sj.leu.2401269","volume":"13","author":"L LoNigro","year":"1999","unstructured":"LoNigro L, Cazzaniga G, DiCataldo A, Pannunzio A, DAniello E, Masera G et al. Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis. Leukemia 1999; 13: 190\u2013195.","journal-title":"Leukemia"},{"key":"BF2403081_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group. Br J Haematol 1976; 33: 451\u2013458.","journal-title":"Br J Haematol"},{"key":"BF2403081_CR24","first-page":"298","volume":"33","author":"JJM Van Dongen","year":"1988","unstructured":"Van Dongen JJM, Adriaansen HJ, Hooijkaas H . Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes. Neth J Med 1988; 33: 298\u2013314.","journal-title":"Neth J Med"},{"key":"BF2403081_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mpo.1085","volume":"36","author":"T Szczepa\u0144ski","year":"2001","unstructured":"Szczepa\u0144ski T, Willemse MJ, Kamps WA, van Wering ER, Langerak AW, van Dongen JJM . Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia \u2013 proposal for an easy strategy. Med Pediatr Oncol 2001; 36: 352\u2013358.","journal-title":"Med Pediatr Oncol"},{"key":"BF2403081_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-8981(91)90246-9","volume":"198","author":"JJM Van Dongen","year":"1991","unstructured":"Van Dongen JJM, Wolvers-Tettero ILM . Analysis of immunoglobulin and T cell receptor genes. Part I: basic and technical aspects. Clin Chim Acta 1991; 198: 1\u201391.","journal-title":"Clin Chim Acta"},{"key":"BF2403081_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/sj.leu.2401427","volume":"13","author":"AW Langerak","year":"1999","unstructured":"Langerak AW, Wolvers-Tettero ILM, van Dongen JJM . Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia 1999; 13: 965\u2013974.","journal-title":"Leukemia"},{"key":"BF2403081_CR28","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V82.10.3063.3063","volume":"82","author":"TM Breit","year":"1993","unstructured":"Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoeven M-AJ, van Wering ER, van Dongen JJM . Southern blot patterns, frequencies and junctional diversity of T-cell receptor \u03b4 gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82: 3063\u20133074.","journal-title":"Blood"},{"key":"BF2403081_CR29","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.4049\/jimmunol.138.8.2687","volume":"138","author":"T Quertermous","year":"1987","unstructured":"Quertermous T, Strauss WM, Van Dongen JJM, Seidman JG . Human T cell gamma chain joining regions and T cell development. J Immunol 1987; 138: 2687\u20132690.","journal-title":"J Immunol"},{"key":"BF2403081_CR30","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/sj.leu.2401540","volume":"13","author":"EJ Moreau","year":"1999","unstructured":"Moreau EJ, Langerak AW, van Gastel-Mol EJ, Wolvers-Tettero ILM, Zhan M, Zhou Q et al. Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1999; 13: 1620\u20131626.","journal-title":"Leukemia"},{"key":"BF2403081_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/sj.leu.2401765","volume":"14","author":"T Szczepa\u0144ski","year":"2000","unstructured":"Szczepa\u0144ski T, Langerak AW, Willemse MJ, Wolvers-Tettero ILM, van Wering ER, van Dongen JJM . T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect \u2018end-stage\u2019 recombinations: implications for minimal residual disease monitoring. Leukemia 2000; 14: 1208\u20131214.","journal-title":"Leukemia"},{"key":"BF2403081_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.leu.2401071","volume":"12","author":"T Szczepa\u0144ski","year":"1998","unstructured":"Szczepa\u0144ski T, Langerak AW, Wolvers-Tettero ILM, Ossenkoppele GJ, Verhoef G, Stul M et al. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 1998; 12: 1081\u20131088.","journal-title":"Leukemia"},{"key":"BF2403081_CR33","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/sj.leu.2400887","volume":"11","author":"AW Langerak","year":"1997","unstructured":"Langerak AW, Szczepa\u0144ski T, van der Burg M, Wolvers-Tettero ILM, van Dongen JJM . Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192\u20132199.","journal-title":"Leukemia"},{"key":"BF2403081_CR34","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1182\/blood.V85.10.2795.bloodjournal85102795","volume":"85","author":"DW Ghali","year":"1995","unstructured":"Ghali DW, Panzer S, Fischer S, Argyriou-Tirita A, Haas OA, Kovar H et al. Heterogeneity of the T-cell receptor delta gene indicating subclone formation in acute precursor B-cell leukemias. Blood 1995; 85: 2795\u20132801.","journal-title":"Blood"},{"key":"BF2403081_CR35","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V93.12.4079","volume":"93","author":"T Szczepa\u0144ski","year":"1999","unstructured":"Szczepa\u0144ski T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs JM, van Wering ER et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V\u2013D\u2013J rearrangements, and are rare in T-cell receptor \u03b1\u03b2 lineage. Blood 1999; 93: 4079\u20134085.","journal-title":"Blood"},{"key":"BF2403081_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/nar\/27.1.209","volume":"27","author":"MP Lefranc","year":"1999","unstructured":"Lefranc MP, Giudicelli V, Ginestoux C, Bodmer J, W M\u00fcller, Bontrop R et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1999; 27: 209\u2013212.","journal-title":"Nucleic Acids Res"},{"key":"BF2403081_CR37","first-page":"177","volume":"22","author":"TM Breit","year":"1994","unstructured":"Breit TM, Van Dongen JJ . Unravelling human T-cell receptor junctional region sequences. Thymus 1994; 22: 177\u2013199.","journal-title":"Thymus"},{"key":"BF2403081_CR38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V75.1.174.174","volume":"75","author":"CH Pui","year":"1990","unstructured":"Pui CH, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK et al. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 1990; 75: 174\u2013179.","journal-title":"Blood"},{"key":"BF2403081_CR39","doi-asserted-by":"crossref","unstructured":"Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR et al. Acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2002; 162\u2013192.","DOI":"10.1182\/asheducation-2002.1.162"},{"key":"BF2403081_CR40","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.leu.2402489","volume":"16","author":"WA Kamps","year":"2002","unstructured":"Kamps WA, Bokkerink JP, Hakvoort-Cammel FG, Veerman AJ, Weening RS, van Wering ER et al. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991\u20131996). Leukemia 2002; 16: 1099\u20131111.","journal-title":"Leukemia"},{"key":"BF2403081_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"MD Amylon","year":"1999","unstructured":"Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 1999; 13: 335\u2013342.","journal-title":"Leukemia"},{"key":"BF2403081_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1200\/JCO.1992.10.1.156","volume":"10","author":"SP Hunger","year":"1992","unstructured":"Hunger SP, Sklar J, Link MP . Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol 1992; 10: 156\u2013163.","journal-title":"J Clin Oncol"},{"key":"BF2403081_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-2141.1999.01476.x","volume":"106","author":"L Dawson","year":"1999","unstructured":"Dawson L, Slater R, Hagemeijer A, Langerak AW, Willemze R, Kluin-Nelemans JC . Secondary T-acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia. Br J Haematol 1999; 106: 104\u2013106.","journal-title":"Br J Haematol"},{"key":"BF2403081_CR44","first-page":"471","volume":"83","author":"V Liso","year":"1998","unstructured":"Liso V, Specchia G, Pannunzio A, Mestice A, Palumbo G, Biondi A . T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. Haematologica 1998; 83: 471\u2013473.","journal-title":"Haematologica"},{"key":"BF2403081_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mpo.2950200310","volume":"20","author":"C Kaplinsky","year":"1992","unstructured":"Kaplinsky C, Frisch A, Cohen IJ, Goshen Y, Jaber L, Yaniv I et al. T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma. Med Pediatr Oncol 1992; 20: 229\u2013231.","journal-title":"Med Pediatr Oncol"},{"key":"BF2403081_CR46","first-page":"554","volume":"84","author":"D Perotti","year":"1999","unstructured":"Perotti D, Sozzi G, Ferrari A, Casanova M, Gambirasio F, Mondini P et al. Cytogenetic and molecular characterization of T-cell acute lymphoblastic leukemia as a second tumor after anaplastic large-cell lymphoma in a boy. Haematologica 1999; 84: 554\u2013557.","journal-title":"Haematologica"},{"key":"BF2403081_CR47","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJM Van Dongen","year":"1999","unstructured":"Van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901\u20131928.","journal-title":"Leukemia"},{"key":"BF2403081_CR48","first-page":"2004","volume":"7","author":"TM Breit","year":"1993","unstructured":"Breit TM, Beishuizen A, Ludwig WD, Mol EJ, Adriaansen HJ, van Wering ER et al. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia 1993; 7: 2004\u20132011.","journal-title":"Leukemia"},{"key":"BF2403081_CR49","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood.V81.8.2110.2110","volume":"81","author":"RO Bash","year":"1993","unstructured":"Bash RO, Crist WM, Shuster JJ, Link MP, Amylon M, Pullen J et al. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood 1993; 81: 2110\u20132117.","journal-title":"Blood"},{"key":"BF2403081_CR50","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.159.9.4341","volume":"159","author":"TM Breit","year":"1997","unstructured":"Breit TM, Verschuren MCM, Wolvers-Tettero ILM, van Gastel-Mol EJ, H\u00e4hlen K, van Dongen JJM . Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. J Immunol 1997; 159: 4341\u20134349.","journal-title":"J Immunol"},{"key":"BF2403081_CR51","first-page":"1031","volume":"15","author":"ER Van Wering","year":"2001","unstructured":"Van Wering ER, van der Linden-Schrever BEM, van der Velden VHJ, Szczepa\u0144ski T, van Dongen JJM . T lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies. Leukemia 2001; 15: 1031\u20131033.","journal-title":"Leukemia"},{"key":"BF2403081_CR52","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.4049\/jimmunol.138.4.1260","volume":"138","author":"JJM Van Dongen","year":"1987","unstructured":"Van Dongen JJM, Quertermous T, Bartram CR, Gold DP, Wolvers-Tettero ILM, Comans-Bitter WM et al. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. J Immunol 1987; 138: 1260\u20131269.","journal-title":"J Immunol"},{"key":"BF2403081_CR53","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood.V93.9.3033.409k39_3033_3043","volume":"93","author":"B Blom","year":"1999","unstructured":"Blom B, Verschuren MC, Heemskerk MH, Bakker AQ, van Gastel-Mol EJ, Wolvers-Tettero IL et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood 1999; 93: 3033\u20133043.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403081","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T04:31:27Z","timestamp":1734150687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,24]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11,1]]}},"alternative-id":["BF2403081"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403081","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,24]]},"assertion":[{"value":"29 April 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}